Ignite Creation Date:
2025-12-24 @ 6:32 PM
Ignite Modification Date:
2026-02-22 @ 7:23 PM
Study NCT ID:
NCT02640157
Status:
COMPLETED
Last Update Posted:
2021-07-30
First Post:
2015-12-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study Comparing Efficacy and Safety of ABT-493/ABT-530 to Sofosbuvir Dosed With Daclatasvir in Adults With HCV Genotype 3 Infection
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-12
Start Date Type:
None
Primary Completion Date:
2016-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-02
Completion Date Type:
ACTUAL
First Submit Date:
2015-12-22
First Submit QC Date:
None
Study First Post Date:
2015-12-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-08-17
Results First Submit QC Date:
None
Results First Post Date:
2017-09-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2017-02-09
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2021-07-09
Last Update Post Date:
2021-07-30
Last Update Post Date Type:
ACTUAL